Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HUMANA INCHUM · Entity 1429 | President & CEO | May 01, 2026 | May 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HUMANA INC
Report date May 01, 2026 · Filed May 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Humana CommonSEC Table I · non-derivative | IndirectSee Footnote | 63,938 |
Reported balance
After 2026-05-01 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-05-01 · Grant · Acquired 35,633 · Balance 63,938 F6: Includes 49,687 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans. F1: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $458.19 · Expires 2031-01-08 | Direct | 29,230 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 29,230 F2: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 1/8/2024, vesting in three annual increments from 1/8/25 to 1/8/27. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $367.21 · Expires 2031-02-21 | Direct | 15,772 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 15,772 F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,183 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 2,183 F4: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27. |
Filing footnotes · ownership attribution and instrument terms
F1: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees.
F2: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 1/8/2024, vesting in three annual increments from 1/8/25 to 1/8/27.
F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
F4: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F5: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27.
F6: Includes 49,687 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2026 Filed May 5, 2026 18:27 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 35,633 | $0.00 | $0.00 |
DisclosureSEC source: 0002006065-26-000004 · form4.xml · nonDerivative · entry 1 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 63,938 F6 · balance_after: Includes 49,687 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans. F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 14:42 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 2,183 | $0.00 | $0.00 |
DisclosureSEC source: 0002006065-26-000002 · form4.xml · derivative · entry 5 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,183 Underlying: Humana Common · 2,183 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27. F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 14:42 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 980 | $279.15 | $273,564.55 |
DisclosureSEC source: 0002006065-26-000002 · form4.xml · nonDerivative · entry 2 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 28,305 F7 · shares: Shares disposed of represent payment of tax liability for shares vesting on 1/8/26. No value was received in return. F6 · balance_after: Includes 14,054 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 14:42 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 2,183 | $0.00 | $0.00 |
DisclosureSEC source: 0002006065-26-000002 · form4.xml · nonDerivative · entry 1 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 29,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 18:58 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 3,372 | $270.16 | $910,962.66 |
DisclosureSEC source: 0002006065-25-000003 · form4.xml · nonDerivative · entry 2 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 27,102 F7 · shares: Shares disposed of represent payment of tax liability for shares vesting on 12/15/25. No value was received in return. F6 · balance_after: Includes 14,054 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 18:58 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 7,707 | $0.00 | $0.00 |
DisclosureSEC source: 0002006065-25-000003 · form4.xml · nonDerivative · entry 1 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 30,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. Read SEC document |
| May 14, 2025 Filed May 16, 2025 20:48 UTC | HUMANA INC HUM · Entity 1429 | PurchaseHumana Common | 6,530 | $229.25 | $1,496,983.56 |
DisclosureSEC source: 0001062993-25-009705 · form4.xml · nonDerivative · entry 1 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 30,474 F7 · price: Average price of shares purchased in reported transaction. F6 · balance_after: Includes 21,761 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 15:19 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 19,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003577 · form4.xml · nonDerivative · entry 1 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 23,944 F6 · balance_after: Includes 21,761 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 16:47 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 2,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000655 · form4.xml · derivative · entry 5 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,366 Underlying: Humana Common · 2,182 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27. F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 16:47 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 978 | $264.68 | $258,857.04 |
DisclosureSEC source: 0001062993-25-000655 · form4.xml · nonDerivative · entry 2 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 4,907 F7 · shares: Shares disposed of represent payment for tax liability on restricted stock units vested on 1/8/25. F6 · balance_after: Includes 2,724 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 16:47 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 2,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000655 · form4.xml · nonDerivative · entry 1 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. Read SEC document |
| December 15, 2024 Filed Dec 17, 2024 19:22 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 392 | $271.68 | $106,496.60 |
DisclosureSEC source: 0001062993-24-020750 · form4.xml · nonDerivative · entry 2 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,693 F7 · shares: Shares disposed of represent payment for tax liability on restricted stock units vested on 12/15/24. F6 · balance_after: Includes 2,724 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:15 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 15,772 | $0.00 Strike: $367.21 | $0.00 |
DisclosureSEC source: 0001062993-24-004244 · form4.xml · derivative · entry 4 Rechtin James A. · CIK 0002006065 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,772 Underlying: Humana Common · 15,772 shares Expires 2031-02-21 F3 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:15 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 4,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004244 · form4.xml · nonDerivative · entry 2 Rechtin James A. · CIK 0002006065 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,085 F6 · shares: Restricted stock units granted to reporting person on 2/21/24. F7 · balance_after: Includes 4,085 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 16:05 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 6,548 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-000737 · form4.xml · derivative · entry 3 Rechtin James A. · CIK 0002006065 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,548 Underlying: Humana Common · 6,548 shares Expires not disclosed F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27. F4 · derivative.expiration_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 16:05 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 29,230 | $0.00 Strike: $458.19 | $0.00 |
DisclosureSEC source: 0001062993-24-000737 · form4.xml · derivative · entry 2 Rechtin James A. · CIK 0002006065 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,230 Underlying: Humana Common · 29,230 shares Expires 2031-01-08 F2 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 1/8/2024, vesting in three annual increments from 1/8/25 to 1/8/27. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 1/8/2024, vesting in three annual increments from 1/8/25 to 1/8/27. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.